{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:16:10Z","timestamp":1784945770655,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Taiwan","award":["RD-111-03"],"award-info":[{"award-number":["RD-111-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aims to assess the association between nicotine replacement therapy (NRT), varenicline, and untreated smoking with the risk of developing eye disorders. We employed a new-user design to investigate the association between NRT use and the incidence of eye disorders by the Taiwan National Health Insurance program. This study included 8416 smokers who received NRT and 8416 smokers who did not receive NRT (control group) matched using propensity scores between 2007 and 2018. After adjustment for relevant factors, a multivariable Cox regression analysis revealed that compared with untreated smokers, NRT use was associated with a significantly reduced risk of macular degeneration (hazard ratio [HR]: 0.34; 95% confidence interval [CI]: 0.13\u20130.87, P\u2009=\u20090.024). When stratified by dose, short-term NRT use (8\u201328 defined daily doses) was associated with significantly lower risk of glaucoma (HR: 0.35; 95% CI: 0.16\u20130.80, P\u2009=\u20090.012) and a trend toward reduced risk of cataract (HR: 0.60; 95% CI: 0.36\u20131.01, P\u2009=\u20090.053) compared to no treatment. However, these associations were not observed with long-term NRT use. The results of this real-world observational study indicate that NRT use, particularly short-term use, was associated with a lower risk of certain eye disorders compared to no treatment for smoking cessation. Long-term NRT use did not demonstrate the same benefits. Thus, short-term NRT may be a beneficial treatment strategy for reducing the risk of eye disorders in smokers attempting to quit. However, further evidence is required to verify these findings and determine the optimal duration of NRT use.<\/jats:p>","DOI":"10.1038\/s41598-024-65813-8","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T18:08:08Z","timestamp":1719425288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of smoking cessation patterns and untreated smoking with glaucoma, cataract, and macular degeneration: a population-based retrospective study"],"prefix":"10.1038","volume":"14","author":[{"given":"Yuan-Tsung","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Tang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"65813_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1440-1843.2008.01476.x","volume":"14","author":"C Wang","year":"2009","unstructured":"Wang, C. et al. Varenicline for smoking cessation: A placebo-controlled, randomized study. Respirology 14, 384\u2013392 (2009).","journal-title":"Respirology"},{"key":"65813_CR2","volume":"10","author":"N Lindson-Hawley","year":"2016","unstructured":"Lindson-Hawley, N. et al. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst. Rev. 10, CD005231 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"65813_CR3","volume":"9","author":"N Lindson","year":"2019","unstructured":"Lindson, N., Klemperer, E., Hong, B., Ord\u00f3\u00f1ez-Mena, J. M. & Aveyard, P. Smoking reduction interventions for smoking cessation. Cochrane Database Syst. Rev. 9, CD013183 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"65813_CR4","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1185\/03007990802177523","volume":"24","author":"R Niaura","year":"2008","unstructured":"Niaura, R. et al. The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: A randomized controlled trial. Curr. Med. Res. Opin. 24, 1931\u20131941 (2008).","journal-title":"Curr. Med. Res. Opin."},{"key":"65813_CR5","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bjo.2008.141168","volume":"92","author":"N Lois","year":"2008","unstructured":"Lois, N., Abdelkader, E., Reglitz, K., Garden, C. & Ayres, J. G. Environmental tobacco smoke exposure and eye disease. Br. J. Ophthalmol. 92, 1304\u20131310 (2008).","journal-title":"Br. J. Ophthalmol."},{"key":"65813_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/1381612823666170111095723","volume":"23","author":"M Nita","year":"2017","unstructured":"Nita, M. & Grzybowski, A. Smoking and eye pathologies. A systemic review. Part II. Retina diseases, uveitis, optic neuropathies, thyroid-associated orbitopathy. Curr. Pharm. Des. 23, 639\u2013654 (2017).","journal-title":"Curr. Pharm. Des."},{"key":"65813_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10792-016-0245-0","volume":"37","author":"V Jain","year":"2017","unstructured":"Jain, V., Jain, M., Abdull, M. M. & Bastawrous, A. The association between cigarette smoking and primary open-angle glaucoma: A systematic review. Int. Ophthalmol. 37, 291\u2013301 (2017).","journal-title":"Int. Ophthalmol."},{"key":"65813_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa117","volume":"2","author":"A Oishi","year":"2020","unstructured":"Oishi, A. et al. Effect of smoking on macular function and retinal structure in retinitis pigmentosa. Brain Commun. 2, fcaa117 (2020).","journal-title":"Brain Commun."},{"key":"65813_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232700","volume":"15","author":"A Hara","year":"2020","unstructured":"Hara, A., Nakazawa, M., Saito, M. & Suzuki, Y. The qualitative assessment of optical coherence tomography and the central retinal sensitivity in patients with retinitis pigmentosa. PLoS\u00a0One 15, e0232700 (2020).","journal-title":"PLoS\u00a0One"},{"key":"65813_CR10","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1167\/iovs.08-1992","volume":"49","author":"MA Sandberg","year":"2008","unstructured":"Sandberg, M. A., Brockhurst, R. J., Gaudio, A. R. & Berson, E. L. Visual acuity is related to parafoveal retinal thickness in patients with retinitis pigmentosa and macular cysts. Investig. Ophthalmol. Vis. Sci. 49, 4568\u20134572 (2008).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"65813_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2019.04.001","volume":"70","author":"E Stef\u00e1nsson","year":"2019","unstructured":"Stef\u00e1nsson, E. et al. Retinal oximetry: Metabolic imaging for diseases of the retina and brain. Prog. Retin. Eye Res. 70, 1\u201322 (2019).","journal-title":"Prog. Retin. Eye Res."},{"key":"65813_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","volume":"166","author":"C Oncken","year":"2006","unstructured":"Oncken, C. et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch. Intern. Med. 166, 1571\u20131577 (2006).","journal-title":"Arch. Intern. Med."},{"key":"65813_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","volume":"178","author":"NL Benowitz","year":"2018","unstructured":"Benowitz, N. L. et al. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: A randomized clinical trial. JAMA Intern. Med. 178, 622\u2013631 (2018).","journal-title":"JAMA Intern. Med."},{"key":"65813_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(15)00320-3","volume":"3","author":"D Kotz","year":"2015","unstructured":"Kotz, D. et al. Cardiovascular and neuropsychiatric risks of varenicline: A retrospective cohort study. Lancet Respir. Med. 3, 761\u2013768 (2015).","journal-title":"Lancet Respir. Med."},{"key":"65813_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.japh.2018.05.017","volume":"58","author":"Z McCormack","year":"2018","unstructured":"McCormack, Z. United States Food and Drug Administration Advisory Committee outcomes and agency approval analysis from 2010 to 2015. J. Am. Pharm. Assoc. 58, 530\u2013533 (2018).","journal-title":"J. Am. Pharm. Assoc."},{"key":"65813_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.7326\/0003-4819-159-6-201309170-00005","volume":"159","author":"RM Anthenelli","year":"2013","unstructured":"Anthenelli, R. M. et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial. Ann. Intern. Med. 159, 390\u2013400 (2013).","journal-title":"Ann. Intern. Med."},{"key":"65813_CR17","volume":"10","author":"F Stead Lindsay","year":"2012","unstructured":"Stead Lindsay, F. & Lancaster, T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst. Rev. 10, CD008286 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"65813_CR18","volume":"5","author":"K Cahill","year":"2013","unstructured":"Cahill, K., Stevens, S., Perera, R. & Lancaster, T. Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database Syst. Rev. 5, CD009329 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"65813_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/07853890.2012.705016","volume":"44","author":"EJ Mills","year":"2012","unstructured":"Mills, E. J. et al. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis. Ann. Med. 44, 588\u2013597 (2012).","journal-title":"Ann. Med."},{"key":"65813_CR20","unstructured":"World Health Organization (2022\/02\/10)."},{"key":"65813_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111879","volume":"9","author":"JA Choi","year":"2014","unstructured":"Choi, J. A., Han, K., Park, Y.-M. & Park, C. K. Age-related association of refractive error with intraocular pressure in the Korea National Health and Nutrition Examination Survey. PLoS\u00a0One 9, e111879 (2014).","journal-title":"PLoS\u00a0One"},{"key":"65813_CR22","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1111\/aos.12355","volume":"92","author":"TH Rim","year":"2014","unstructured":"Rim, T. H., Nam, J. S., Choi, M., Lee, S. C. & Lee, C. S. Prevalence and risk factors of visual impairment and blindness in Korea: The Fourth Korea National Health and Nutrition Examination Survey in 2008\u20132010. Acta Ophthalmol. 92, e317\u2013e325 (2014).","journal-title":"Acta Ophthalmol."},{"key":"65813_CR23","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/14656566.2016.1197203","volume":"17","author":"JL Barboza","year":"2016","unstructured":"Barboza, J. L., Patel, R., Patel, P. & Hudmon, K. S. An update on the pharmacotherapeutic interventions for smoking cessation. Expert Opin. Pharmacother. 17, 1483\u20131496 (2016).","journal-title":"Expert Opin. Pharmacother."},{"key":"65813_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamaophthalmol.2014.4908","volume":"133","author":"H-C Cheng","year":"2015","unstructured":"Cheng, H.-C. et al. Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol. 133, 269\u2013275 (2015).","journal-title":"JAMA Ophthalmol."},{"key":"65813_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/IJG.0b013e31824083ca","volume":"22","author":"J-W Cheng","year":"2013","unstructured":"Cheng, J.-W. et al. The prevalence of primary glaucoma in mainland China: A systematic review and meta-analysis. J. Glaucoma 22, 301\u2013306 (2013).","journal-title":"J. Glaucoma"},{"key":"65813_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.survophthal.2013.09.003","volume":"59","author":"H-K Cho","year":"2014","unstructured":"Cho, H.-K. & Kee, C. Population-based glaucoma prevalence studies in Asians. Surv. Ophthalmol. 59, 434\u2013447 (2014).","journal-title":"Surv. Ophthalmol."},{"key":"65813_CR27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0161-6420(03)00243-4","volume":"110","author":"S-Y Tsai","year":"2003","unstructured":"Tsai, S.-Y., Hsu, W.-M., Cheng, C.-Y., Liu, J.-H. & Chou, P. Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology 110, 1089\u20131095 (2003).","journal-title":"Ophthalmology"},{"key":"65813_CR28","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1167\/iovs.08-1803","volume":"49","author":"S-J Chen","year":"2008","unstructured":"Chen, S.-J. et al. Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Investig. Ophthalmol. Vis. Sci. 49, 3126\u20133133 (2008).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"65813_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","volume":"2","author":"JL Lund","year":"2015","unstructured":"Lund, J. L., Richardson, D. B. & St\u00fcrmer, T. The active comparator, new user study design in pharmacoepidemiology: Historical foundations and contemporary application. Curr. Epidemiol. Rep. 2, 221\u2013228 (2015).","journal-title":"Curr. Epidemiol. Rep."},{"key":"65813_CR30","unstructured":"Greifer, N. Estimating effects after matching. MatchIt: Nonparametric Preprocessing for Parametric Causal Inference. https:\/\/cran.r-project.org\/web\/packages\/MatchIt\/vignettes\/estimating-effects.html (accessed on 1 August 2022) (2021)."},{"key":"65813_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/01621459.2020.1840383","volume":"117","author":"A Abadie","year":"2022","unstructured":"Abadie, A. & Spiess, J. Robust post-matching inference. J. Am. Stat. Assoc. 117, 983\u2013995 (2022).","journal-title":"J. Am. Stat. Assoc."},{"key":"65813_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/EE9.0000000000000085","volume":"4","author":"JD Higbee","year":"2020","unstructured":"Higbee, J. D. et al. Estimating long-term pollution exposure effects through inverse probability weighting methods with Cox proportional hazards models. Environ. Epidemiol. 4, e085 (2020).","journal-title":"Environ. Epidemiol."},{"key":"65813_CR33","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511802843","volume-title":"Bootstrap Methods and Their Application","author":"AC Davison","year":"1997","unstructured":"Davison, A. C. & Hinkley, D. V. Bootstrap Methods and Their Application (Cambridge University Press, 1997)."},{"key":"65813_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318297429c","volume":"53","author":"SR Austin","year":"2015","unstructured":"Austin, S. R., Wong, Y.-N., Uzzo, R. G., Beck, J. R. & Egleston, B. L. Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med. Care 53, e65 (2015).","journal-title":"Med. Care"},{"key":"65813_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","volume":"100","author":"VV Kapetanakis","year":"2016","unstructured":"Kapetanakis, V. V. et al. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis. Br. J. Ophthalmol. 100, 86\u201393 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"65813_CR36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"Y-C Liu","year":"2017","unstructured":"Liu, Y.-C., Wilkins, M., Kim, T., Malyugin, B. & Mehta, J. S. Cataracts. Lancet 390, 600\u2013612 (2017).","journal-title":"Lancet"},{"key":"65813_CR37","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"65813_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1167\/iovs.18-25845","volume":"60","author":"S Wang","year":"2019","unstructured":"Wang, S. & Bao, X. Hyperlipidemia, blood lipid level, and the risk of glaucoma: A meta-analysis. Investig. Ophthalmol. Vis. Sci. 60, 1028\u20131043 (2019).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"65813_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.7727\/wimj.2011.103","volume":"61","author":"B Heydari","year":"2012","unstructured":"Heydari, B., Kazemi, T., Zarban, A. & Ghahramani, S. Correlation of cataract with serum lipids, glucose and antioxidant activities a case\u2013control study. West Indian Med. J. 61, 230\u2013234 (2012).","journal-title":"West Indian Med. J."},{"key":"65813_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-021-00550-2","volume":"79","author":"AG Mersha","year":"2021","unstructured":"Mersha, A. G., Eftekhari, P., Bovill, M., Tollosa, D. N. & Gould, G. S. Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: A systematic review and meta-analysis. Arch. Public Health 79, 1\u201314 (2021).","journal-title":"Arch. Public Health"},{"key":"65813_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/IJG.0000000000002092","volume":"31","author":"G Mahmoudinezhad","year":"2022","unstructured":"Mahmoudinezhad, G. et al. Smoking cessation may reduce risk of visual field progression in heavy smokers. J. Glaucoma 31, 796\u2013803 (2022).","journal-title":"J. Glaucoma"},{"key":"65813_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.ophtha.2022.06.017","volume":"129","author":"G Mahmoudinezhad","year":"2022","unstructured":"Mahmoudinezhad, G. et al. Impact of smoking on visual field progression in a long-term clinical follow-up. Ophthalmology 129, 1235\u20131244 (2022).","journal-title":"Ophthalmology"},{"key":"65813_CR43","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.ophtha.2020.06.009","volume":"127","author":"P Founti","year":"2020","unstructured":"Founti, P. et al. Risk factors for visual field deterioration in the United Kingdom Glaucoma Treatment Study. Ophthalmology 127, 1642\u20131651 (2020).","journal-title":"Ophthalmology"},{"key":"65813_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.addbeh.2014.08.008","volume":"40","author":"E Beard","year":"2015","unstructured":"Beard, E., Bruguera, C., McNeill, A., Brown, J. & West, R. Association of amount and duration of NRT use in smokers with cigarette consumption and motivation to stop smoking: A national survey of smokers in England. Addict. Behav. 40, 33\u201338 (2015).","journal-title":"Addict. Behav."},{"key":"65813_CR45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/146222003100073676","volume":"5","author":"K Haustein","year":"2003","unstructured":"Haustein, K., Batra, A., Landfeldt, B. & Westin, A. The effect of short-term or long-term reduction on smoking cessation; results from a placebo controlled smoking reduction study with the nicotine gum. Nicotine Tob. Res. 5, 278 (2003).","journal-title":"Nicotine Tob. Res."},{"key":"65813_CR46","doi-asserted-by":"publisher","first-page":"b1024","DOI":"10.1136\/bmj.b1024","volume":"338","author":"D Moore","year":"2009","unstructured":"Moore, D. et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ 338, b1024 (2009).","journal-title":"BMJ"},{"key":"65813_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15569527.2022.2144874","volume":"42","author":"S Karimi","year":"2022","unstructured":"Karimi, S., Nouri, H., Mahmoudinejad-Azar, S. & Abtahi, S.-H. Smoking and environmental tobacco smoke exposure: Implications in ocular disorders. Cutan. Ocul. Toxicol. 42, 1\u20137 (2022).","journal-title":"Cutan. Ocul. Toxicol."},{"key":"65813_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/bjo-2022-322325","volume":"108","author":"J-Y Kai","year":"2022","unstructured":"Kai, J.-Y. et al. Smoking, dietary factors and major age-related eye disorders: An umbrella review of systematic reviews and meta-analyses. Br. J. Ophthalmol. 108, 51\u201357 (2022).","journal-title":"Br. J. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65813-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65813-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65813-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T18:10:48Z","timestamp":1719425448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65813-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["65813"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-65813-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"6 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14788"}}